This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Juan Pablo Cueva-Garcia: Innovator in Neurological Treatments
Introduction
Juan Pablo Cueva-Garcia is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological diseases. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Juan Pablo Cueva-Garcia holds a patent for "GPR52 modulators and methods of use." This patent relates to compounds that modulate the activity of G-protein coupled receptor 52 (GPR52). The compounds, along with their pharmaceutically acceptable salts and compositions, are directed towards methods useful in the treatment or prophylaxis of neurological diseases and related conditions. He has 1 patent to his name.
Career Highlights
Cueva-Garcia is currently employed at Neurocrine Biosciences, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients suffering from neurological disorders.
Collaborations
Throughout his career, Juan has collaborated with notable colleagues, including Neil Ashweek and Collin Regan. These partnerships have enhanced the scope and impact of his research.
Conclusion
Juan Pablo Cueva-Garcia is a key figure in the innovation of treatments for neurological diseases. His contributions through patents and collaborations are shaping the future of pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile